DNA cytometry and kinetics of rat urothelial lesions during chemical carcinogenesis

Oncology Reports

Volumn 21, Issue 1, 2009, Pages 247-252

  Palmeira, C ^a,b   Oliveira, Paula A ^c   Arantes Rodrigues, R ^c   Colaco A ^c   de La Cruz, P L F ^d   Lopes, C ^a,e   Santos, L ^a,b  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^c UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^e UNIVERSITY OF PORTO   (Portugal)

Author keywords

DNA image cytometry; Proliferation index; Rat; Urothelial lesions

Indexed keywords

DNA; KI 67 ANTIGEN; N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE;

ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CYTOMETRY; DIPLOIDY; DNA CONTENT; FEMALE; HISTOPATHOLOGY; HYPERPLASIA; IMMUNOREACTIVITY; NONHUMAN; PAPILLARY CARCINOMA; PAPILLOMA; PRIORITY JOURNAL; RAT; UROGENITAL TRACT TUMOR; UROTHELIUM; ANIMAL; BLADDER TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FISCHER 344 RAT; GENETICS; METABOLISM; PATHOLOGY; PLOIDY;

ANIMALS; BUTYLHYDROXYBUTYLNITROSAMINE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DNA, NEOPLASM; FEMALE; KI-67 ANTIGEN; PLOIDIES; RATS; RATS, INBRED F344; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 61449453466     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000215     Document Type: Article

References (28)

1. Sauter G, Algaba F, Amin M, et al: Non-invasive urothelial neoplasias. WHO classification of non-invasive papillary urothelial tumors. In: Pathology and Genetics: Tumors of the Urinary System and Male Genital Organs. Eble JN, Sauter G, Epstein JI and Sesterhenn I (eds). World Health Organization Classification of Tumors. IARCC Press, Lyon, 2004.
2. Oliveira PA, Colaco A, De la Cruz PLF and Lopes C: Experimental bladder carcinogenesis - rodent models. Exp Oncol 28: 2-11, 2006.
3. Montironi R, Mazzucchelli R, Scarpelli M, Lopez-Beltran A and Cheng L: Morphological diagnosis of urothelial neoplasms. J Clin Pathol 61: 3-10, 2008.
4. Raatz H, Böcking A and Hauptmann S: Prognostic impact of DNA-image-cytometry in neuroendocrine (carcinoid) tumours. Cell Oncol 26: 81-88, 2004.
5. Gockel I, Kammerer P, Brieger J, Heinrich UR, Mann WJ, Bittinger F, Eckardt VF and Junginger T: Image cytometric DNA analysis of mucosal biopsies in patients with primary achalasia. World J Gastroenterol 12: 3020-3025, 2006.
6. Riháková P, Brychtová S, Kotrsová L, Pilka R and Kolár Z: DNA ploidy correlates with grade, proliferation and clinical outcome but not with presence of human oncogenic HPVs or expression of Bcl-2 in preneoplastic and neoplastic lesions of the uterine cervix. Neoplasma 48: 274-277, 2001.
7. Cai T, Margallo E, Nesi G, Giubilei G, Rizzo M and Bartoletti R: Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up. Oncol Rep 15: 213-219, 2006.
8. Cattoretti G, Becker MH, Key G, Duchrow M, Schlüter C, Galle J and Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357-363, 1992.
9. Kontogeorgos G: Predictive markers of pituitary adenoma behavior. Neuroendocrinology 83: 179-188, 2006.
10. Lee S: Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract. Cancer 78: 1787-1881, 1996.
11. Matsuura H, Hayashi N, Kawamura J, Shiraishi T and Yatani R: Prognostic significance of Ki-67 expression in advanced prostate cancers in relation to disease progression after androgen ablation. Eur Urol 37: 212-217, 2000.
12. Santos L, Amaro T, Costa C, Pereira S, Bento MJ, Lopes P, Oliveira J, Criado B and Lopes C: Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification. Int J Cancer 105: 267-272, 2003.
13. Hidalgo Grau LA, Badia JM, Admella Salvador C, Soler Monsó T, Feliu Canaleta J, Gubern Nogués JM and Suñol Sala J: Gallbladder carcinoma: the role of p53 protein overexpression and Ki-67 antigen expression as prognostic markers. HPB (Oxford) 6: 174-180, 2004.
14. Xuan YH, Choi YL, Shin YK, Kook MC, Chae SW, Park SM, Chae HB and Kim SH: An immunohistochemical study of the expression of cell-cycle-regulated proteins p53, cyclin D1, RB, p27, Ki67 and MSH2 in gallbladder carcinoma and its precursor lesions. Histol Histopathol 20: 59-66, 2005.
15. Oliveira PA, Palmeira C, Colaço A, De la Cruz LF and Lopes C: DNA content analysis, expression of Ki-67 and p53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with mitomycin C and bacillus Calmette-Guérin. Anticancer Res 26: 2995-3004, 2006.
16. Cohen SM, Ohnishi T, Clark NM, He J and Arnold LL: Investigations of rodent urinary bladder carcinogens: collection, processing, and evaluation of urine and bladders. Toxicol Pathol 35: 337-347, 2007.
17. Epstein JI, Amin MB, Reuter VR and Mostofi FK: The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 22: 1435-1448, 1998.
18. Oliveira PA, Palmeira C, Lourenço LM and Lopes CA: Evaluation of DNA content in preneoplastic changes of mouse urinary bladder induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. J Exp Clin Cancer Res 24: 609-616, 2005.
19. Oliveira PA, Adega F, Palmeira CA, Chaves RM, Colaço AA, Guedes-Pinto H, De la Cruz PLF and Lopes CA: DNA study of bladder papillary tumours chemically induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in Fisher rats. Int J Exp Pathol 88: 39-46, 2007.
20. Oliveira P, Palmeira C, Colaço A, De la Cruz PLF and Lopes C: Cell proliferation and DNA content in rat urothelial lesions after repeat intravesical instillations of mitomycin C and bacillus Calmette-Guérin. Urol Int 80: 90-97, 2008.
21. Nowell PC: The clonal evolution of tumor cell populations. Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression. Science 194: 23-28, 1976.
22. Staibano S, Franco R, Tranfa F, Mezza E, Lo Muzio L, Strianese D, Errico ME, Bufo P, Ferrara G, Somma P, Mansueto G, Greco I, Fiorillo A, Bonavolontà G and De Rosa G: Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior. Anticancer Res 24: 249-257, 2004.
23. Mandard AM, Denoux Y, Herlin P, Duigou F, van de Vijver MJ, Clahsen PC, van den Broek L, Sahmoud TM, Henry-Amar M and van de Velde CJ: Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density. Cancer 89: 1748-1757, 2000.
24. Hosaka Y, Rainwater LM, Grant CS, Young WF Jr, Farrow GM, van Heerden JA and Lieber MM: Adrenocortical carcinoma: nuclear deoxyribonucleic acid ploidy studied by flow cytometry. Surgery 102: 1027-1034, 1987.
25. Joensuu H and Klemi PJ: DNA aneuploidy in adenomas of endocrine organs. Am J Pathol 132: 145-151, 1988.
26. Burger M, Denzinger S, Hartmann A, Wieland WF, Stoehr R and Obermann EC: Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade. Br J Cancer 96: 1711-1715, 2007.
27. Blanes A and Diaz-Cano SJ: DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions. Hum Pathol 37: 1295-1303, 2006.
28. Kerkhof M, Steyerberg EW, Kusters JG, van Dekken H, van Vuuren AJ, Kuipers EJ and Siersema PD: Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus. Cancer Biomark 4: 1-10, 2008.